Corporate Overview

Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies on the leading edge of cancer biology. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact.

Read more

Key Highlights

91

Million in cash /equivalents as of 9/30/21

1200

Patients received momelotinib in clinical trials

3

Phase 3 trial data to be submitted with NDA

2

Billion in annual sales for approved JAKi

Latest News

View all news

Investor Presentation

Latest Events

View All Events

Latest Quarterly Reports

View All Financial Reports